Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Secondary Hyperparathyroidism in the Uremic Patient. A Study Comparing Alfacalcidol and Paricalcitol

NCT00469599 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.

NCT NCT00469599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00469599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Secondary Hyperparathyroidism in the Uremic Patient. A Study Comparing Alfacalcidol and Paricalcitol
Lead sponsor
Zealand University Hospital
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2007
Completion date
October 31, 2010
Enrollment
86 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, secondary hyperparathyroidism, vitamin d deficiency